Widespread stock-outs of anti-tuberculosis medicine are endangering sufferers and accelerating transmission throughout Nigeria, regardless of assurances by the Federal Government that funds have been permitted to safe provides.
The alarm was raised on the ongoing coaching of journalists on DR-TB protection organised by the COMBAT DR-TB Project of the Civil Society for the Eradication of Tuberculosis in Nigeria, TB Network, in Abuja.
Health officers on the coaching confirmed that amenities nationwide have been with out important TB commodities for nearly two months, with present shares inadequate to final until December.
“We have a stock-out of TB medications nationwide. The drugs we have now cannot take us up to December,” one officer stated.
Most alarming, they identified, is the absence of TB Preventive Therapy, TPT, given to contacts of TB sufferers and folks dwelling with HIV to forestall development to energetic illness.
“There is no single TPT anywhere in this country. All the TPT we have are expired,” an officer stated.
Faced with extra sufferers than medicines, employees admitted to rationing therapy in opposition to coverage.
“You have 20 drugs, but you diagnosed 50. They are dividing the drugs for these 20 to these 50, thinking more drugs will come,” one officer stated. “I have 50 patients but 20 kits. Why watch these 50 die?”
Independent knowledge confirms the disaster. At a press briefing in Abuja on June 12, 2026, the Network of People Living with HIV/AIDS in Nigeria, NEPWHAN, referred to as on the Federal Government to declare the stock-out a nationwide public well being emergency.
A report on NEPWHAN’s first-quarter community-led monitoring protecting 2,135 amenities throughout the 36 states and FCT discovered that 64.2 per cent of amenities reported stock-outs of no less than one important TB commodity, significantly Drug Susceptible TB Category 1 medicine, whereas 58.2 per cent recorded shortages of GeneXpert cartridges and sputum supplies.
The physique warned that sufferers recognized with TB are being informed to return weeks later as a result of medicine aren’t accessible. For a illness the place therapy quickly reduces infectiousness, the delay means sufferers stay infectious at dwelling, in markets, colleges and correctional centres.
It disclosed that as on the time of the briefing, “there are no confirmed government funds for 2026 TB interventions, and the 54 million dollars counterpart funding commitment is yet to be released.”
$54m promise made in March, nothing on the bottom
The promise of $54 million was first made three months earlier. At the 2026 Pre-World TB Day briefing in Abuja on March 17, 2026, organised by Stop TB Partnership Nigeria, the Director of Public Health, Federal Ministry of Health and Social Welfare, Dr Charles Nzelu, introduced that $54 million had been permitted for procurement of TB and HIV medicine to forestall stock-outs.
Speaking at that briefing, Dr Nzelu stated the federal government was making large strides in addressing challenges within the well being sector and that the long-term funding was a part of a method to make sure Nigeria doesn’t expertise stock-outs.
He defined that the transfer grew to become obligatory after forecasts indicated that some TB medicines supported by the Global Fund may run out, and that the ministry had set in movement the equipment to acquire commodities utilizing a part of the $200 million sector-wide allocation introduced final yr.
He additionally introduced the nationwide rollout of the Pluslife Mini Dock, a near-point-of-care diagnostic platform, and the deployment of over 1,000 items of molecular diagnostic tools.
Seven months after that March 17 briefing, well being employees on the TB Network coaching say nothing is on the bottom to point out for it. Facilities stay empty, TPT is unavailable, and the promised procurement has not resulted in medicine on cabinets.
The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, had additionally pledged $52.3 million as co-financing for the 2023-2026 Global Fund Round 7 Cycle, a part of which was earmarked for TB commodities. TB Network stated it projected on the time that the nation would danger important stock-outs by June 2026 if procurement weren’t expedited — a projection now enjoying out.
Funding hole
TB Network National Coordinator, Olayide Akanni, stated donors who traditionally procured TB medicine have informed authorities to take possession. For the subsequent three-year cycle, the Global Fund will present funding for just one yr, leaving two years to the federal government.
Stop TB Partnership lists Nigeria amongst 10 international locations with essentially the most pressing wants, requiring $85.4 million for 2025/2026.
Nigeria has a 70 per cent funding hole in TB, with solely six per cent of the nationwide TB finances coming from home sources. While the federal government earmarked about N73.4 billion for TB medicine for 2026, advocates say no funds have been launched.
“Nigerian government needs to wake up! It’s not enough to make promises outside the country,” Akanni stated. “One year down the line, funds have not come, drugs have not been procured.”
In a letter dated October 10, 2026, Ref: TBN/ADM/101/001/0943, TB Network requested the Minister for rapid procurement and accelerated mechanisms to forestall future disruptions.
Why it issues
Head of Training on the National Institute of Public Health and Infectious Diseases, Dr Eunice Jiya Chitumu, stated stock-outs are harmful in 3 ways.
“First, it prolongs sickness and will increase danger of loss of life. Nigeria recorded 71,000 TB-related deaths in 2023, in accordance with WHO.
“Second, it forces treatment interruption, which breeds drug-resistant TB that is harder, longer and more expensive to treat. Third, it fuels community spread,” she defined.
Nigeria ranks first in Africa and sixth globally amongst high-burden TB and TB/HIV international locations.
The WHO 2025 Global TB Report estimates about 510,000 new TB instances yearly, together with 61,000 kids. Nigeria recorded about 8,200 instances of multidrug-resistant or rifampicin-resistant TB in 2024, however solely 3,090 had been began on therapy.
Notifications have grown from 106,533 in 2018 to 405,324 in 2024 and 458,534 in 2025, displaying progress in detection. But with out medicine, case discovering alone is not going to cease transmission.
TB prognosis and therapy stay formally free in all government-approved DOTS centres. What is lacking, well being employees say, is the medication itself.
“The important thing is we don’t have drugs, and we risk an epidemic if funding is not released,” one speaker on the coaching stated.
We’ve received the sting. Get real-time studies, breaking scoops, and unique angles delivered straight to your telephone. Don’t accept stale information. Join LEADERSHIP NEWS on WhatsApp for twenty-four/7 updates →
